Primary |
|
White Blood Cell Count Increased |
100.0% |
|
Secondary |
Arthrogram |
28.9% |
X-ray Limb |
21.1% |
Joint Injury |
11.3% |
X-ray |
9.0% |
Arthroscopy |
3.8% |
Drug Exposure During Pregnancy |
3.8% |
Ovarian Cancer |
3.4% |
Plasma Cell Myeloma |
2.6% |
Hypokalaemia |
2.3% |
Prophylaxis |
1.9% |
Bone Marrow Conditioning Regimen |
1.5% |
Cellulite |
1.5% |
Hyponatraemia |
1.5% |
Prophylaxis Against Graft Versus Host Disease |
1.5% |
Epidural Analgesia |
1.1% |
General Anaesthesia |
1.1% |
Pain Management |
1.1% |
Scan Myocardial Perfusion |
1.1% |
Arthralgia |
0.8% |
Bone Scan |
0.8% |
|
Septic Arthritis Staphylococcal |
37.7% |
Death |
11.6% |
No Adverse Event |
5.8% |
Pain |
5.8% |
Injury |
4.3% |
Purulent Discharge |
4.3% |
Foetal Heart Rate Abnormal |
2.9% |
Hypernatraemia |
2.9% |
Joint Effusion |
2.9% |
Medication Error |
2.9% |
Reversible Posterior Leukoencephalopathy Syndrome |
2.9% |
Staphylococcal Sepsis |
2.9% |
Wrong Technique In Drug Usage Process |
2.9% |
Catatonia |
1.4% |
Fatigue |
1.4% |
Hyperventilation |
1.4% |
Intestinal Perforation |
1.4% |
Mycobacterium Fortuitum Infection |
1.4% |
Phlebitis |
1.4% |
Serum Sickness |
1.4% |
|
Concomitant |
Prophylaxis |
26.8% |
Product Used For Unknown Indication |
14.9% |
Dehydration |
8.5% |
Cough |
8.0% |
Fluid Replacement |
6.8% |
Medication Dilution |
6.5% |
Drug Use For Unknown Indication |
5.2% |
Chemotherapy |
4.2% |
Depression |
3.9% |
Constipation |
3.8% |
Therapeutic Procedure |
2.8% |
Mineral Supplementation |
1.5% |
Nausea |
1.4% |
Rheumatoid Arthritis |
1.2% |
Pain |
1.0% |
Vitamin Supplementation |
0.8% |
Vomiting |
0.8% |
Adverse Event |
0.7% |
Premedication |
0.6% |
Back Pain |
0.5% |
|
Vomiting |
18.2% |
Lung Neoplasm Malignant |
17.5% |
Death |
7.2% |
Pyrexia |
6.6% |
Renal Failure Acute |
6.1% |
Nephropathy Toxic |
5.0% |
Thrombocytopenia |
4.8% |
Pneumonia |
3.7% |
White Blood Cell Count Increased |
3.5% |
Unresponsive To Stimuli |
3.1% |
Pain |
2.8% |
Adenocarcinoma Of Colon |
2.6% |
Nephropathy |
2.6% |
Tremor |
2.6% |
Weight Decreased |
2.6% |
Pulmonary Embolism |
2.4% |
Sepsis |
2.2% |
Tumour Lysis Syndrome |
2.2% |
Urinary Tract Infection |
2.2% |
International Normalised Ratio Increased |
2.0% |
|